Drug Induced Movement Disorders (eBook, PDF)

Redaktion: Factor, Stewart; Weiner, William; Lang, Anthony

• Format: PDF

Produktbeschreibung

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Seitenzahl: 480
• Erscheinungstermin: 24. April 2008
• Englisch
• ISBN-13: 9781405137553
• Artikelnr.: 38281343

Autorenporträt

Dr. Stewart Factor, DO. Professor of Neurology, Riley Family Chair in Parkinson's Disease, Director, Parkinson's Disease and Movement Disorder Program, Albany Medical Center Dr. Anthony E. Lang, MD. Movement Disorder Clinic, Toronto Western Hospital Dr. William J. Weiner, MD. Chair, Department of Neurology, University of Maryland School of Medicine

Inhaltsangabe

Section 1: General Considerations.
Chapter 1: Movement Disorders: Approach, Definitions and differential
Diagnosis.
Martin Cloutier, Anthony E. Lang.
Chapter 2: Rating Scales for Movement Disorders.
Wonodi I, Hong EH, Avila MT, Gunvant Thaker.
Chapter 3: Spontaneous movement disorders in psychiatric patients.
Irene Richard, Christopher O'Brien, Roger Kurlan.
Section 2: Antipsychotics.
Chapter 4: Pharmacology of typical and atypical agents.
Gary Remington, Shitij Kapur.
Chapter 5: Acute Drug-induced Dystonia.
Michael F. Mazurek, Patricia I. Rosebush.
Chapter 6: Drug-Induced Parkinsonism.
Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez.
Chapter 7: Acute Akathisia.
Author: Lenard A. Adler, John Rotrosen, Burt Angrist.
Chapter 8: Neuroleptic Malignant Syndrome.
Stewart A. Factor.
Chapter 9: Classical Tardive Dyskinesia.
Thomas M. Hyde, MD, Jose A. Apud, Whitney C. Fisher, Michael F. Egan.
Chapter 10: Tardive dyskinesia Variants.
Skidmore F, Weiner W, Burke R.
Chapter 11: Movement Disorders caused by atypical antipsychotics.
Karen E. Anderson.
Chapter 12: Commentary: Is Tardive dyskinesia disappearing?James Lohr, MD.
.
.
Section 3: Dopaminomimetic Drugs.
Chapter 13: Dyskinesia induced by levodopa and dopamine agonists in
Parkinson's disease.
John G. Nutt, Matthew Brodsky.
Chapter 14: Stimulant Drugs.
Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner.
Section 5: Other Drugs.
Chapter 15: Antidepressants.
Marie L. Moro-de-Casillas, David E. Riley.
Chapter 16: Anticonvulsants.
John C. Morgan, Madeline Harrison.
Chapter 17: Miscellaneous Drugs.
Daniel Tarsy